08:00 , Nov 17, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Cytomegalovirus (CMV) Bone marrow stromal cell antigen 2 (BST2; CD317) In vitro studies suggest inhibiting BST2 could help treat CMV...
07:00 , Oct 27, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Hepatic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Hepatic disease Hepatic disease IL-15; bone marrow stromal cell antigen 2 (BST2; CD317) Mouse and patient sample studies suggest blocking IL-15 or depleting dendritic cells could...
08:00 , Dec 3, 2009 |  BC Innovations  |  Distillery Techniques

Technology: Assays & screens

Approach Summary Licensing status Publication and contact information Assays & screens Proteomics-based identification of potential lymphoma drug targets A proteomics assay could be useful for identifying new targets to treat lymphoma. In lymphoma-bearing mice, infusion...